RHINISENG®: Safety of the basic vaccination scheme vaccination and revaccination and the booster vaccination

Strona główna Wiedza RHINISENG®: Safety of the basic vaccination scheme vaccination and revaccination and the booster vaccination

RHINISENG®: Safety of the basic vaccination scheme vaccination and revaccination and the booster vaccination

RHINISENG® is a new vaccine against progressive (PAR) and non-progressive atrophic rhinitis (NPAR) indicated for pregnant sows and gilts to passively protect their offspring. The RHINISENG® recommended vaccination scheme includes a basic vaccination scheme (vaccination 8-6 weeks before farrowing and revaccination 4-3 weeks before farrowing) and a booster dose (4-3 weeks before the subsequent farrowing). This study evaluated the vaccine pre-clinical safety under experimental conditions.

O tym artykule

Autorzy

Montané, J.; Monells, M.; Ruiz, M.C.; Roca, M.; Camprodon, A.; March, R.; Sitjà, M.

Streszczenie

The mean body temperature did not exceed 38.7ºC in vaccinated sows (38.66 ± 0.38ºC after revaccination), always reaching the maximum value 6 hours after vaccine administration (Figure 1). The normal temperature for sows in gestation is 38.7 ± 0.3 ºC (Straw et al., 1999). No abnormal local or systemic reactions were observed. Both, the basic vaccination scheme and the booster scheme had no effects on the reproductive performance of sows. No abortions were observed over the study period or teratogenic effects on the progeny. No differences were observed in the liveborn piglet, stillborn piglet and mummified foetus average between control and vaccinated sows (Table 1). RHINISENG® demonstrated an optimal safety under experimental conditions in pregnant sows and gilts.

Powiązane usługi

Powiązane produkty

Udostępnij na